23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
25 Settembre 2024 - 1:30PM
23andMe Holding Co., (Nasdaq: ME), a leading human genetics and
preventive health company, today released a new report on the
genetics of emotional eating for 23andMe+ Premium members,
informing them if they are at a higher likelihood of frequent
emotional eating.
Emotional eating occurs when an individual frequently eats to
cope with difficult feelings1. It often involves eating
high-calorie, unhealthy foods, despite not feeling physically
hungry, and can result in overeating. Emotional hunger is not
satiated by food in the same way that physical hunger is, so while
emotional eating may feel good in the moment, it can cause physical
discomfort and feelings of guilt or shame. According to a study by
the American Psychological Association, 27% of U.S. adults say they
eat to manage stress. In addition, research has found that mental
health conditions, especially depression and anxiety, are major
causes of emotional eating.
23andMe’s Emotional Eating PRS report* is based on a statistical
model known as a polygenic risk score (PRS), developed by 23andMe
through its proprietary research database. The report takes into
account an individual’s genetic results at many genetic markers,
along with their genetic ancestry and birth sex to estimate the
likelihood of frequent emotional eating. According to published
data, it's estimated that genetics explains 9-60% of predisposition
to emotional eating2.
“Many people experience emotional eating from time to time, but
when emotional eating becomes extreme it can be a problem, causing
weight gain and potentially contributing to health problems like
high cholesterol and diabetes,” said Noura Abul-Husn, MD, PhD, Vice
President of Genomic Health at 23andMe. “Knowing a person’s genetic
likelihood for experiencing emotional eating can help them identify
new strategies early on, like removing unhealthy foods from their
pantries or finding enjoyable alternatives like going on a walk. We
hope this report can help provide an added resource for those who
may experience emotional eating.”
The Emotional Eating PRS report was developed by 23andMe
scientists and clinical experts using 23andMe’s database of genetic
and health information contributed by consented research
participants. A published white paper provides full details on the
science and methodology behind 23andMe’s PRS technology.
While genetic factors may play a role, they do not account for
every possible factor that could impact a person’s likelihood of
experiencing emotional eating. To learn more about the new
Emotional Eating PRS report and how to become a 23andMe+ Premium
member, visit https://www.23andme.com/membership/.
1
https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss/art-200473422
https://onlinelibrary.wiley.com/doi/pdf/10.1038/oby.2009.389,
https://pubmed.ncbi.nlm.nih.gov/15755823/,
https://pubmed.ncbi.nlm.nih.gov/18689360/
About 23andMe23andMe is a genetics-led consumer
healthcare and therapeutics company empowering a healthier future.
For more information, please visit investors.23andme.com.
Forward-Looking StatementsThis press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, including. All
statements, other than statements of historical fact, included or
incorporated in this press release are forward-looking statements.
The words "believes," "anticipates," "estimates," "plans,"
"expects," "intends," "may," "could," "should," "potential,"
"likely," "projects," “predicts,” "continue," "will," “schedule,”
and "would" or, in each case, their negative or other variations or
comparable terminology, are intended to identify forward-looking
statements, although not all forward-looking statements contain
these identifying words. These forward-looking statements are
predictions based on 23andMe’s current expectations and projections
about future events and various assumptions. 23andMe cannot
guarantee that it will actually achieve the plans, intentions, or
expectations disclosed in its forward-looking statements and you
should not place undue reliance on 23andMe’s forward-looking
statements. These forward-looking statements involve a number of
risks, uncertainties (many of which are beyond the control of
23andMe), or other assumptions that may cause actual results or
performance to differ materially from those expressed or implied by
these forward-looking statements. The forward-looking statements
contained herein are also subject generally to other risks and
uncertainties that are described from time to time in the Company’s
filings with the Securities and Exchange Commission, including
under Item 1A, “Risk Factors” in the Company’s most recent Annual
Report on Form 10-K, as filed with the Securities and Exchange
Commission, and as revised and updated by our Quarterly Reports on
Form 10-Q and Current Reports on Form 8-K. The statements made
herein are made as of the date of this press release and, except as
may be required by law, 23andMe undertakes no obligation to update
them, whether as a result of new information, developments, or
otherwise.
Contact
Informationpress@23andme.cominvestors@23andme.com
* The 23andMe Emotional Eating PRS report is based on a genetic
model that includes data and insights from 23andMe consented
research participants and incorporates more than 2,000 genetic
variants to provide information on the likelihood of developing
emotional eating. The report does not describe a person’s overall
likelihood, does not account for lifestyle or family history and
has not been reviewed by the US Food and Drug Administration. The
Emotional Eating PRS report is not intended to tell you anything
about your current state of health, or to be used to make medical
decisions or determine any treatment.
Grafico Azioni 23andMe (NASDAQ:ME)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni 23andMe (NASDAQ:ME)
Storico
Da Gen 2024 a Gen 2025